Arca
Skip to content
Tools
Tools

vir

An antiviral. A longer stem in front often says which virus or which viral enzyme it hits.

  • Drugs containing vir: 108
  • Approved somewhere: 46
  • With a US drug page: 28

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
vir
Class
Antivirals
Most common targets
POL (25), NS3, NS4A (16), NS5B (12), NS5A (10), P (6), DNA polymerase catalytic subunit (5), NA (4), CCR5 (4)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names containing vir or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
OseltamivirApprovedNANeuraminidase inhibitor
ZanamivirApprovedNANeuraminidase inhibitor
Peramivir anhydrousApprovedNANeuraminidase inhibitor
Laninamivir octanoatePhase 3NANeuraminidase inhibitor
LaninamivirPhase 2——
DaclatasvirApprovedNS5ANonstructural protein 5A inhibitor
ElbasvirApprovedNS5ANonstructural protein 5A inhibitor
LedipasvirApprovedNS5ANonstructural protein 5A inhibitor
OmbitasvirApprovedNS5ANonstructural protein 5A inhibitor
PibrentasvirApprovedNS5ANonstructural protein 5A inhibitor
VelpatasvirApprovedNS5ANonstructural protein 5A inhibitor
YimitasvirPhase 3——
CoblopasvirPhase 2——
OdalasvirPhase 2NS5ANonstructural protein 5A inhibitor
RavidasvirPhase 2NS5ANonstructural protein 5A inhibitor
RuzasvirPhase 2NS5ANonstructural protein 5A inhibitor
SamatasvirPhase 2NS5ANonstructural protein 5A inhibitor
SofosbuvirApprovedNS5BRNA-directed RNA polymerase inhibitor
DasabuvirApprovedNS5BRNA-directed RNA polymerase inhibitor
BeclabuvirPhase 3NS5BRNA-directed RNA polymerase negative allosteric modulator
BemnifosbuvirPhase 3——
DeleobuvirPhase 3NS5BRNA-directed RNA polymerase inhibitor
AdafosbuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
FilibuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
LomibuvirPhase 2NS5BRNA-directed RNA polymerase negative allosteric modulator
NesbuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
RadalbuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
SetrobuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
TegobuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
UprifosbuvirPhase 2NS5BRNA-directed RNA polymerase inhibitor
LenacapavirApprovedGAGStructural capsid protein inhibitor
BersacapavirPhase 2HBCAGCore antigen modulator
CanocapavirPhase 2——
ClaficapavirPhase 2——
DezecapavirPhase 2——
SuricapavirPhase 2——
ZelicapavirPhase 2——
AbacavirApprovedPOLHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
Entecavir anhydrousApprovedPDNA polymerase/reverse transcriptase inhibitor
Abacavir hydroxyacetatePhase 2——
MetacavirPhase 2——
FamciclovirApprovedDNA polymerase catalytic subunitHuman herpesvirus 1 DNA polymerase inhibitor
PenciclovirApprovedDNA polymerase catalytic subunitHuman herpesvirus 1 DNA polymerase inhibitor
ValganciclovirApprovedDNA polymerase catalytic subunitHuman herpesvirus 1 DNA polymerase inhibitor
GanciclovirApprovedDNA polymerase catalytic subunitHuman herpesvirus 1 DNA polymerase inhibitor
Valomaciclovir stearatePhase 2——
ValomaciclovirPhase 1——
Adefovir dipivoxilApprovedPDNA polymerase/reverse transcriptase inhibitor
BrincidofovirApprovedOPG071DNA polymerase inhibitor
Tenofovir alafenamideApprovedPOLHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
Tenofovir disoproxilApprovedPOL, PHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
Cidofovir anhydrousApprovedDNA polymerase catalytic subunitHuman herpesvirus 1 DNA polymerase inhibitor
AdefovirPhase 3PDNA polymerase/reverse transcriptase inhibitor
BesifovirPhase 3——
PradefovirPhase 3PDNA polymerase/reverse transcriptase inhibitor
Tenofovir anhydrousPhase 3POL, PHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
Rovafovir etalafenamidePhase 2POLHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
Tenofovir exalidexPhase 2POL, REVERSE, TRANSCRIPTASEHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
CelgosivirPhase 2Alpha glucosidaseAlpha glucosidase inhibitor
AmprenavirApprovedPOLHuman immunodeficiency virus type 1 protease inhibitor
AtazanavirApprovedPOLHuman immunodeficiency virus type 1 protease inhibitor
DarunavirApprovedPOLHuman immunodeficiency virus type 1 protease inhibitor
FosamprenavirApprovedPOLHuman immunodeficiency virus type 1 protease inhibitor
NelfinavirApprovedPOLHuman immunodeficiency virus type 1 protease inhibitor
RitonavirApprovedPOL, Cytochrome P450 3AHuman immunodeficiency virus type 1 protease inhibitor
TipranavirApprovedPOLHuman immunodeficiency virus type 1 protease inhibitor
Indinavir anhydrousApprovedPOLHuman immunodeficiency virus type 1 protease inhibitor
LopinavirApprovedPOLHuman immunodeficiency virus type 1 protease inhibitor
SaquinavirApprovedPOLHuman immunodeficiency virus type 1 protease inhibitor
BrecanavirPhase 2POLHuman immunodeficiency virus type 1 protease inhibitor
TelinavirPhase 1POLHuman immunodeficiency virus type 1 protease inhibitor
BoceprevirApprovedNS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
SimeprevirApprovedNS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
TelaprevirApprovedNS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
AsunaprevirApprovedNS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
GlecaprevirApprovedNS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
Grazoprevir anhydrousApprovedNS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
ParitaprevirApprovedNS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
VoxilaprevirApprovedNS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
DanoprevirPhase 3NS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
FaldaprevirPhase 3NS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
FuraprevirPhase 3NS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
NarlaprevirPhase 3NS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
VaniprevirPhase 3NS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
SovaprevirPhase 2NS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
VedroprevirPhase 2NS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
Ciluprevir—NS3, NS4AHepatitis C virus serine protease, NS3/NS4A inhibitor
DoravirineApprovedPOLHuman immunodeficiency virus type 1 reverse transcriptase negative allosteric modulator
EtravirineApprovedPOLHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
RilpivirineApprovedPOLHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
DapivirinePhase 3POLHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
BavtavirinePhase 2——
CapravirinePhase 2POLHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
DepulfavirinePhase 2——
ElsulfavirinePhase 2——
EmivirinePhase 2POLHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
LersivirinePhase 2POLHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
UlonivirinePhase 2——
MaravirocApprovedCCR5C-C chemokine receptor type 5 antagonist
AplavirocPhase 3CCR5C-C chemokine receptor type 5 antagonist
CenicrivirocPhase 3CCR5, CCR2C-C chemokine receptor type 5 antagonist
VicrivirocPhase 3CCR5C-C chemokine receptor type 5 antagonist
FomivirsenApprovedMajor intermediate early region 2 mRNAMajor intermediate early region 2 mRNA antisense inhibitor
Fomivirsen sodiumPhase 2Major intermediate early region 2 mRNAMajor intermediate early region 2 mRNA antisense inhibitor
BepirovirsenPhase 3mRNAmRNA antisense inhibitor
MiravirsenPhase 2microRNA 122microRNA 122 antisense inhibitor
Bepirovirsen sodiumPhase 1——
RadavirsenPhase 1——

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.